Provided by Tiger Trade Technology Pte. Ltd.

WisdomTree BioRevolution Fund

23.29
+1.024.59%
Post-market: 23.290.00000.00%16:10 EDT
Volume:3K
Turnover:62.19K
Market Cap:4.66M
PE:- -
High:23.40
Open:23.08
Low:23.01
Close:22.27
52wk High:24.20
52wk Low:14.71
Shares:200.00K
Float Shares:200.00K
Volume Ratio:0.31
T/O Rate:1.34%
Dividend:0.77
Dividend Rate:3.31%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly: Under Terms of Agreement, Lilly Will Acquire Merida and Pay up to $2.875 Bln in Cash

THOMSON REUTERS
·
Aug 31

Lilly to Acquire Merida Biosciences to Advance Treatments for Serious Autoimmune and Allergic Diseases

THOMSON REUTERS
·
Aug 31

Eli Lilly - Deal Expected to Close in Q4 2026 Subject to Regulatory Approvals

THOMSON REUTERS
·
Aug 31

August Turmoil: Bessent's Intervention and the Quiet Reveal of Policy's Hidden Hand

Deep News
·
Aug 30

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Dow Jones
·
Aug 29

US Stocks Weekly: AI Refuel

Reuters
·
Aug 29

Eli Lilly (LLY) Wins FDA Approval For Mounjaro Heart Risk Reduction

Simply Wall St.
·
Aug 29

BioNTech Stock Falls on Cancer Vaccine Setback Days After Moderna's Big Win

Dow Jones
·
Aug 29

BioNTech on Track for Worst Day Since March After Ending Colorectal Cancer Trial

Reuters
·
Aug 29

Moderna Stock Falls on $2B Notes Deal: Is the Cancer Rally Still Intact?

TradingKey
·
Aug 28

Sector Update: Health Care Stocks Mixed Pre-Bell Friday

MT Newswires Live
·
Aug 28

Argus Research Upgrades Moderna to Buy From Hold, $180 Price Target

MT Newswires Live
·
Aug 28

Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes

Reuters
·
Aug 28

Moderna Price Target Announced at $180.00/Share by Argus Research

Dow Jones
·
Aug 28

U.S. Stocks on the MOVE-Cytokinetics, Moderna, Ulta Beauty

Reuters
·
Aug 28

Success After a Century of Failures: Inside Moderna and Merck's Cancer Vaccine Breakthrough

Reuters
·
Aug 28

Moderna Prices $2.6 Billion Convertible Notes due 2032

MT Newswires Live
·
Aug 28

Moderna Rises After Upsized $2.6 Bln Convertible Bond Sale

Reuters
·
Aug 28

FDA Approves Lilly's Mounjaro to Cut Cardiovascular Event Risk in High-Risk Type 2 Diabetes Adults

Reuters
·
Aug 28

FDA Approves Lilly's Mounjaro (Tirzepatide) to Reduce Cardiovascular Risk in Adults with Type 2 Diabetes

THOMSON REUTERS
·
Aug 28